Around the EQUATOR With Clin-STAR: AI-Based Randomized Controlled Trial Challenges and Opportunities in Aging Research
- PMID: 39907384
- PMCID: PMC12100690
- DOI: 10.1111/jgs.19362
Around the EQUATOR With Clin-STAR: AI-Based Randomized Controlled Trial Challenges and Opportunities in Aging Research
Abstract
The CONSORT 2010 statement is a guideline that provides an evidence-based checklist of minimum reporting standards for randomized trials. With the rapid growth of Artificial Intelligence (AI) based interventions in the past 10 years, the CONSORT-AI extension was created in 2020 to provide guidelines for AI-based randomized controlled trials (RCT). The Clin-STAR "Around the EQUATOR" series features existing reported standards while also highlighting the inherent complexities of research involving research of older participants. In this work, we propose that when designing AI-based RCTs involving older adults, researchers adopt a conceptual framework (CONSORT-AI-5Ms) designed around the 5Ms (Mind, Mobility, Medications, Matters most, and Multi-complexity) of Age-Friendly Healthcare Systems. Employing the 5Ms in this context, we provide a detailed rationale and include specific examples of challenges and potential solutions to maximize the impact and value of AI RCTs in an older adult population. By combining the original intent of CONSORT-AI with the 5Ms framework, CONSORT-AI-5Ms provides a patient-centered and equitable perspective to consider when designing AI-based RCTs to address the diverse needs and challenges associated with geriatric care.
© 2025 The Author(s). Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Conflict of interest statement
Betsy Yang and Caroline Park are supported by the Palo Alto VA GRECC Advanced Fellowship. Betsy Yang is a paid Suki AI consultant. Deborah M. Kado is a federal employee, receives royalties from UpToDate for authorship, is a WndrHLTH consultant, and funded by: Starkey Laboratories incorporated grant, Stanford Wu Tsai Human Performance Alliance grant, and NIH fundings: R01AG065876, R01AR0811, ES032649, AG066671. All authors declare no conflicts of interest.
Figures

Similar articles
-
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.Nat Med. 2020 Sep;26(9):1364-1374. doi: 10.1038/s41591-020-1034-x. Epub 2020 Sep 9. Nat Med. 2020. PMID: 32908283 Free PMC article. Review.
-
Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines.Nat Commun. 2024 Feb 22;15(1):1619. doi: 10.1038/s41467-024-45355-3. Nat Commun. 2024. PMID: 38388497 Free PMC article.
-
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension.BMJ. 2020 Sep 9;370:m3164. doi: 10.1136/bmj.m3164. BMJ. 2020. PMID: 32909959 Free PMC article.
-
Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines.Trials. 2021 Jan 6;22(1):11. doi: 10.1186/s13063-020-04951-6. Trials. 2021. PMID: 33407780 Free PMC article.
-
Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI†.J Pathol. 2021 Jan;253(1):14-16. doi: 10.1002/path.5565. Epub 2020 Oct 31. J Pathol. 2021. PMID: 33016344
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous